Quantbot Technologies LP Provention Bio, Inc. Transaction History

Quantbot Technologies LP

  • $2.36 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$4.52 - $10.57 $9,582 - $22,408
2,120 New
2,120 $22,000
Q1 2021

May 14, 2021
SELL
$10.12 - $19.45 $3,015 - $5,796
-298 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$11.79 - $18.94 $3,513 - $5,644
298 New
298 $5,000
Q1 2020

May 13, 2020
SELL
$5.42 - $17.75 $8,785 - $28,772
-1,621 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$5.84 - $14.9 $9,466 - $24,152
1,621 New
1,621 $24,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email